We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 22 results
  1. Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

    RNA-binding proteins (RBPs)-RNA networks have contributed to cancer development. Circular RNAs (circRNAs) are considered as protein recruiters;...

    Ri-**n Chen, Shui-Dan Xu, ... Feng-Wei Wang in Signal Transduction and Targeted Therapy
    Article Open access 02 April 2024
  2. MEX3A promotes colorectal cancer migration, invasion and EMT via regulating the Wnt/β-catenin signaling pathway

    Background

    Mex-3 RNA binding family members are well-established to be important in cancer development and progression. However, the functions of...

    Jiannan Xu, Songyao Chen, ... Yulong He in Journal of Cancer Research and Clinical Oncology
    Article Open access 25 June 2024
  3. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way

    Background

    Hepatocellular carcinoma (HCC) is most common malignant tumor worldwide, and one of the most lethal malignancies. MEX3A, RNA-binding...

    Shiji Fang, Liyun Zheng, ... Jiansong Ji in Hepatology International
    Article 17 July 2023
  4. The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4

    Purpose

    Breast cancer (BC) is the most frequent malignant tumor in women worldwide with exceptionally high morbidity. The RNA-binding protein MEX3A...

    Wenhu Chen, Liqiang Hu, ... Chen Huang in Breast Cancer Research and Treatment
    Article Open access 11 July 2023
  5. Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer

    Improved insight into the molecular mechanisms of triple-negative breast cancer (TNBC) is required to predict prognosis and develop a new therapeutic...

    Rong Jia, Yujie Weng, ... Pengfei Ning in Reproductive Sciences
    Article 01 March 2021
  6. Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker

    Purpose

    Colon cancer is highly heterogeneous in terms of the immune and stromal microenvironment, genomic integrity, and oncogenic properties;...

    Zhujiang Dai, **ang Peng, ... Yun Liu in Journal of Cancer Research and Clinical Oncology
    Article 20 July 2023
  7. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease

    Research showing that microRNAs (miRNAs) are versatile regulators of gene expression has instigated tremendous interest in cardiovascular research....

    Donato Santovito, Christian Weber in Nature Reviews Cardiology
    Article 18 March 2022
  8. Nicht kodierende Ribonukleinsäure im kardiovaskulären System

    The discovery of regulatory noncoding RNA molecules (ncRNA) revolutionized our previous understanding of gene expression. As shown by extensive...

    S. Engelhardt, S. Dimmeler, ... K. Zarnack in Der Kardiologe
    Article 17 March 2022
  9. Mechanisms of metastatic colorectal cancer

    Despite extensive research and improvements in understanding colorectal cancer (CRC), its metastatic form continues to pose a substantial challenge,...

    Adrià Cañellas-Socias, Elena Sancho, Eduard Batlle in Nature Reviews Gastroenterology & Hepatology
    Article 28 May 2024
  10. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer

    Ovarian clear-cell cancer is a rare subtype of epithelial ovarian cancer with unique clinical and biological features. Despite optimal cytoreductive...

    Zesi Liu, Chunli **g, Fandou Kong in Journal of Ovarian Research
    Article Open access 12 February 2024
  11. Drug-tolerant persister cells in cancer: the cutting edges and future directions

    Drug-tolerant persister (DTP) cell populations were originally discovered in antibiotic-resistant bacterial biofilms. Similar populations with...

    Yi Pu, Lu Li, ... Shensi Shen in Nature Reviews Clinical Oncology
    Article 25 September 2023
  12. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway

    Objective

    CD147 is an important glycoprotein that participates in the progression of diverse cancers. This study aims to explore the specific function...

    Ning Zhang, Zhouzhong Liu, ... Yuli Wang in Respiratory Research
    Article Open access 25 October 2023
  13. Exploiting RIG-I-like receptor pathway for cancer immunotherapy

    RIG-I-like receptors (RLRs) are intracellular pattern recognition receptors that detect viral or bacterial infection and induce host innate immune...

    Yangfu Jiang, Hongying Zhang, ... Hui Hua in Journal of Hematology & Oncology
    Article Open access 08 February 2023
  14. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients

    Background

    The immune infiltration of patients with colon cancer (CC) is closely associated with RNA-binding proteins (RBPs). However,...

    Di Sun, Kui-Sheng Yang, ... Zheng-bing Wang in World Journal of Surgical Oncology
    Article Open access 26 October 2021
  15. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies

    Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation of iron-dependent membrane-localized lipid...

    Qian Zhou, Yu Meng, ... Guangtong Deng in Signal Transduction and Targeted Therapy
    Article Open access 08 March 2024
  16. Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia

    The chromatin-associated AAA+ ATPases Tip48 and Tip49 are the core components of various complexes implicated in diverse nuclear events such as DNA...

    Ayuna Hattori, Emi Takamatsu-Ichihara, ... Issay Kitabayashi in Leukemia
    Article 25 July 2023
  17. Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma

    Detailed characterizations of genomic alterations have not identified subtype-specific vulnerabilities in adult gliomas. Map** gliomas into...

    **g Feng, Zheng Zhao, ... **aolong Fan in Frontiers of Medicine
    Article 16 January 2023
  18. Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer

    Cancer stem cells (CSCs) possess the capacity for self-renewal and the potential to differentiate into non-CSCs. The recent discoveries of dynamic...

    Michitaka Nakano, Yoshikane Kikushige, ... Koichi Akashi in Oncogene
    Article 04 September 2018
  19. Neurodevelopmental signatures of narcotic and neuropsychiatric risk factors in 3D human-derived forebrain organoids

    It is widely accepted that narcotic use during pregnancy and specific environmental factors (e.g., maternal immune activation and chronic stress) may...

    Michael Notaras, Aiman Lodhi, ... Dilek Colak in Molecular Psychiatry
    Article Open access 22 June 2021
  20. Harnessing innate immune pathways for therapeutic advancement in cancer

    The innate immune pathway is receiving increasing attention in cancer therapy. This pathway is ubiquitous across various cell types, not only in...

    Ankang Hu, Li Sun, ... Ying Mao in Signal Transduction and Targeted Therapy
    Article Open access 25 March 2024
Did you find what you were looking for? Share feedback.